Impact of Prophylactic Use of PEG-rhG-CSF on First-Line Immunochemotherapy in Advanced NSCLC: A Cohort Study.

JTO Clin Res Rep · 2025 · PMC11773054 · PMID 39877027

Europe PMC DOI

hedged sentence

0.9500

closest p · 19.0× alpha

0.9500

boldest claim

The sentences

did not reach statistical significancep = 0.95not close (p > 0.1)

Nevertheless, this did not reach statistical significance (23.8 versus 20.0 mo, HR = 0.96, 95% CI: 0.30–3.1, p = 0.95).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.